Patient characteristics
| . | Patient 1 . | Patient 2 . | Patient 3 . |
|---|---|---|---|
| Age, y | 2.9 | 1.8 | 1.8 |
| Sex | Female | Female | Male |
| Bone marrow infiltration at diagnosis | 74% | 38% | 81% |
| Cytogenetics | t(12;21)(p13;q22) | Normal karyotype | Normal karyotype |
| Residual disease at day 15 | 2 × 10−4 | 17.3 × 10−2 | 2 × 10−3 |
| Residual disease at day 29 | No MRD | 4.2 × 10−3 | No MRD |
| . | Patient 1 . | Patient 2 . | Patient 3 . |
|---|---|---|---|
| Age, y | 2.9 | 1.8 | 1.8 |
| Sex | Female | Female | Male |
| Bone marrow infiltration at diagnosis | 74% | 38% | 81% |
| Cytogenetics | t(12;21)(p13;q22) | Normal karyotype | Normal karyotype |
| Residual disease at day 15 | 2 × 10−4 | 17.3 × 10−2 | 2 × 10−3 |
| Residual disease at day 29 | No MRD | 4.2 × 10−3 | No MRD |
MRD indicates minimal residual disease.